Proteomic identification of the macrophage-capping protein as a protein contributing to the malignant features of hepatocellular carcinoma

Kazuya Kimura, Hidenori Ojima, Daisuke Kubota, Marimu Sakumoto, Yukiko Nakamura, Tsuyoshi Tomonaga, Tmoo Kosuge, Tadashi Kondo

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) is one of the most deadly cancers worldwide. We performed a proteomic study to understand the molecular mechanisms underlying metastasis in HCC. Among the 3491 protein spots observed by two-dimensional difference gel electrophoresis (2D-DIGE), we found that 197 and 88 protein spots had statistically significant differences in intensity between tumor and non-tumor tissues and between the tumors with and without vascular invasion, respectively. Mass spectrometry was used to identify the proteins corresponding to those protein spots. We found that compared to tumor tissues without vascular invasion, those with vascular invasion showed markedly upregulated expression of the macrophage-capping protein (CapG). The association of increased CapG expression with vascular invasion in the tumor tissues was confirmed by western blotting. CapG expression levels were equal for non-tumor tissues and tumor tissues without venous invasion, as assessed by 2D-DIGE and western blotting. Silencing of CapG reduced tumor invasion without affecting the proliferation of the HCC cells. These observations suggested that CapG is involved in the process of metastasis by promoting the invasiveness of tumor cells. It may therefore be worth investigating the clinical usefulness of CapG as a biomarker in risk-stratification therapy and as a therapeutic target in HCC.

Original languageEnglish
Pages (from-to)362-373
Number of pages12
JournalJournal of Proteomics
Volume78
DOIs
Publication statusPublished - 2013 Jan 14
Externally publishedYes

Fingerprint

Macrophages
Proteomics
Tumors
Hepatocellular Carcinoma
Two-Dimensional Difference Gel Electrophoresis
Tissue
Blood Vessels
Neoplasms
Proteins
Western Blotting
Neoplasm Metastasis
Biomarkers
Electrophoresis
Mass spectrometry
Gels
Cells
Mass Spectrometry
Association reactions
Therapeutics

Keywords

  • Biomarker
  • Hepatocellular carcinoma
  • Macrophage-capping protein (CapG)
  • Two-dimensional difference gel electrophoresis
  • Venous invasion

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics

Cite this

Proteomic identification of the macrophage-capping protein as a protein contributing to the malignant features of hepatocellular carcinoma. / Kimura, Kazuya; Ojima, Hidenori; Kubota, Daisuke; Sakumoto, Marimu; Nakamura, Yukiko; Tomonaga, Tsuyoshi; Kosuge, Tmoo; Kondo, Tadashi.

In: Journal of Proteomics, Vol. 78, 14.01.2013, p. 362-373.

Research output: Contribution to journalArticle

Kimura, Kazuya ; Ojima, Hidenori ; Kubota, Daisuke ; Sakumoto, Marimu ; Nakamura, Yukiko ; Tomonaga, Tsuyoshi ; Kosuge, Tmoo ; Kondo, Tadashi. / Proteomic identification of the macrophage-capping protein as a protein contributing to the malignant features of hepatocellular carcinoma. In: Journal of Proteomics. 2013 ; Vol. 78. pp. 362-373.
@article{b0c1dfa5eb5540dcaad1bfd4efed9769,
title = "Proteomic identification of the macrophage-capping protein as a protein contributing to the malignant features of hepatocellular carcinoma",
abstract = "Hepatocellular carcinoma (HCC) is one of the most deadly cancers worldwide. We performed a proteomic study to understand the molecular mechanisms underlying metastasis in HCC. Among the 3491 protein spots observed by two-dimensional difference gel electrophoresis (2D-DIGE), we found that 197 and 88 protein spots had statistically significant differences in intensity between tumor and non-tumor tissues and between the tumors with and without vascular invasion, respectively. Mass spectrometry was used to identify the proteins corresponding to those protein spots. We found that compared to tumor tissues without vascular invasion, those with vascular invasion showed markedly upregulated expression of the macrophage-capping protein (CapG). The association of increased CapG expression with vascular invasion in the tumor tissues was confirmed by western blotting. CapG expression levels were equal for non-tumor tissues and tumor tissues without venous invasion, as assessed by 2D-DIGE and western blotting. Silencing of CapG reduced tumor invasion without affecting the proliferation of the HCC cells. These observations suggested that CapG is involved in the process of metastasis by promoting the invasiveness of tumor cells. It may therefore be worth investigating the clinical usefulness of CapG as a biomarker in risk-stratification therapy and as a therapeutic target in HCC.",
keywords = "Biomarker, Hepatocellular carcinoma, Macrophage-capping protein (CapG), Two-dimensional difference gel electrophoresis, Venous invasion",
author = "Kazuya Kimura and Hidenori Ojima and Daisuke Kubota and Marimu Sakumoto and Yukiko Nakamura and Tsuyoshi Tomonaga and Tmoo Kosuge and Tadashi Kondo",
year = "2013",
month = "1",
day = "14",
doi = "10.1016/j.jprot.2012.10.004",
language = "English",
volume = "78",
pages = "362--373",
journal = "Journal of Proteomics",
issn = "1874-3919",
publisher = "Elsevier",

}

TY - JOUR

T1 - Proteomic identification of the macrophage-capping protein as a protein contributing to the malignant features of hepatocellular carcinoma

AU - Kimura, Kazuya

AU - Ojima, Hidenori

AU - Kubota, Daisuke

AU - Sakumoto, Marimu

AU - Nakamura, Yukiko

AU - Tomonaga, Tsuyoshi

AU - Kosuge, Tmoo

AU - Kondo, Tadashi

PY - 2013/1/14

Y1 - 2013/1/14

N2 - Hepatocellular carcinoma (HCC) is one of the most deadly cancers worldwide. We performed a proteomic study to understand the molecular mechanisms underlying metastasis in HCC. Among the 3491 protein spots observed by two-dimensional difference gel electrophoresis (2D-DIGE), we found that 197 and 88 protein spots had statistically significant differences in intensity between tumor and non-tumor tissues and between the tumors with and without vascular invasion, respectively. Mass spectrometry was used to identify the proteins corresponding to those protein spots. We found that compared to tumor tissues without vascular invasion, those with vascular invasion showed markedly upregulated expression of the macrophage-capping protein (CapG). The association of increased CapG expression with vascular invasion in the tumor tissues was confirmed by western blotting. CapG expression levels were equal for non-tumor tissues and tumor tissues without venous invasion, as assessed by 2D-DIGE and western blotting. Silencing of CapG reduced tumor invasion without affecting the proliferation of the HCC cells. These observations suggested that CapG is involved in the process of metastasis by promoting the invasiveness of tumor cells. It may therefore be worth investigating the clinical usefulness of CapG as a biomarker in risk-stratification therapy and as a therapeutic target in HCC.

AB - Hepatocellular carcinoma (HCC) is one of the most deadly cancers worldwide. We performed a proteomic study to understand the molecular mechanisms underlying metastasis in HCC. Among the 3491 protein spots observed by two-dimensional difference gel electrophoresis (2D-DIGE), we found that 197 and 88 protein spots had statistically significant differences in intensity between tumor and non-tumor tissues and between the tumors with and without vascular invasion, respectively. Mass spectrometry was used to identify the proteins corresponding to those protein spots. We found that compared to tumor tissues without vascular invasion, those with vascular invasion showed markedly upregulated expression of the macrophage-capping protein (CapG). The association of increased CapG expression with vascular invasion in the tumor tissues was confirmed by western blotting. CapG expression levels were equal for non-tumor tissues and tumor tissues without venous invasion, as assessed by 2D-DIGE and western blotting. Silencing of CapG reduced tumor invasion without affecting the proliferation of the HCC cells. These observations suggested that CapG is involved in the process of metastasis by promoting the invasiveness of tumor cells. It may therefore be worth investigating the clinical usefulness of CapG as a biomarker in risk-stratification therapy and as a therapeutic target in HCC.

KW - Biomarker

KW - Hepatocellular carcinoma

KW - Macrophage-capping protein (CapG)

KW - Two-dimensional difference gel electrophoresis

KW - Venous invasion

UR - http://www.scopus.com/inward/record.url?scp=84872684774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872684774&partnerID=8YFLogxK

U2 - 10.1016/j.jprot.2012.10.004

DO - 10.1016/j.jprot.2012.10.004

M3 - Article

C2 - 23085225

AN - SCOPUS:84872684774

VL - 78

SP - 362

EP - 373

JO - Journal of Proteomics

JF - Journal of Proteomics

SN - 1874-3919

ER -